Compounds > tofacitinib

tofacitinib and Hypereosinophilic-Syndrome

tofacitinib has been researched along with Hypereosinophilic-Syndrome* in 2 studies

Other Studies

2 other study(ies) available for tofacitinib and Hypereosinophilic-Syndrome

ArticleYear
Topical tofacitinib for the management of lymphocytic-variant hypereosinophilic syndrome with cutaneous involvement.
    Dermatologic therapy, 2022, Volume: 35, Issue:7

    Topics: Humans; Hypereosinophilic Syndrome; Piperidines; Pyrimidines

2022
Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib.
    The Journal of investigative dermatology, 2017, Volume: 137, Issue:4

    Topics: Adult; Aged; Female; Humans; Hypereosinophilic Syndrome; Janus Kinase Inhibitors; Male; Middle Aged; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Skin Diseases

2017